No one escapes being affected by cancer. We all know someone, perhaps even a family member who has been diagnosed with cancer. According to the National Cancer Institute, more than 1.6 million people will be diagnosed with cancer in 2012. In fact, it is estimated that each person has a 41% chance of developing cancer during his or her lifetime. But new discoveries by researchers have started to change the outcome of a cancer diagnosis. In a recently published article in Nature, two researchers at CU boulder have found a possible solution hiding at the ends of our DNA. According to Professor Cech, "This is an exciting scientific discovery that gives us a new way of looking at the problem of cancer.” The researchers, Tom Cech and Leslie Leinwand, found the solution by studying how telomerase functions in our cells. In normal people, telomerase helps us keep our cells healthy and young.
We're finding out that there's a lot more to malnutrition among infants and children than just not getting enough to eat, or enough high-quality food. Individuals may develop malnutrition as a result of what is or isn't growing in their gut, where food gets processed. It's a fascinating insight with significant implications for treating a deadly world problem. In addition to getting sufficient good food, malnutrition could be addressed with novel dietary and microbial therapeutics, effectively optimizing a person's ability to draw nutrients and calories from the food and drink they take in, as well as making sure the immune system is being supported rather than compromised in the process.
Tags: CA, Bioscience research, Midwest, Washington University, WashU, University of Colorado, microbiome, The Bill and Melinda Gates Foundation, Northwest, Biofrontiers Institute, Southwest, UCDMC, BioResearch Product Faire Event, Funding, Genomics, CO, St Louis, Sacramento, Boulder, UCO, UC Davis
The Jennie Smoly Caruthers Biotechnology Building on the East Campus of the University of Colorado Boulder is already welcoming researchers to their new labs and offices, and on April 26 there will be an official dedication ceremony for the 330,000sf innovative life science facility. While the university is still waiting for state funding to construct a fifth wing for teaching space, the current building is scheduled to be fully occupied by June. As we reported in a widely-read earlier blog on this much-anticipated research complex, one of the key tenants will be the Biofrontiers Institute, formerly the CIMB. Joining them are the Department of Chemical and Biological Engineering and the Division of Biochemistry.
Tags: Bioresearch, flow cytometry, Biofrontiers Institute, New research facilities, Southwest, University of Colorado Boulder, BioResearch Product Faire Event, biotech industry, Colorado, new construction, Boulder, UCO, BRPF, construction
Last Spring, we wrote a popular blog (New CU-Boulder Biotech Building to Anchor Local Bioscience Industry) on the Colorado Institute in Molecular Biotechnology (CIMB), its future home in the new Jenny Smoly Caruthers Biotechnology Building, and the potential impact on the local economy. While the Caruthers biotech building has pushed back its opening date from November 2011 to early in 2012, the CIMB is going strong and has in fact reorganized to become the new Biofrontiers Institute.
In November of 2011 the new $145M Jennie Smoly Caruthers Biotechnology Building is set to open on the East Campus of the University of Colorado at Boulder. LEED-certified, the building will be home to the Colorado Initiative in Molecular Biology (CIMB), which formed in 2003 to foster multidisciplinary molecular biotechnology research at CU.